Job title: Global Scientific Advisor, Biomarkers & Clinical Bioanalysis TMED
Dr. Rob Pomponio is currently a Global Scientific Advisor of Biomarkers and Clinical Bioanalysis at Sanofi. His 33-year career as a Human Geneticist has spanned basic research in the discovery and characterization of genes and mutations that contribute to human disease in Orphan Disease and Oncology. He has led R&D and Clinical Laboratories with Genzyme and Sanofi to characterize novel biomarkers and developed sensitive and robust clinical assays that support patient monitoring and contribute to successful clinical trial endpoints. Working within the Translational Medicine and Early Development platform at Sanofi, he devises biomarker plans that contribute understanding of biomarkers of disease, potential safety and toxicology risks and efficacy/response that are used to support approval of Sanofi’s therapeutic products.
11.40 | 8.40 Panel Discussion: Conversations Between Pharma and Diagnostic Providers 11:40 am
• How is technology development in pharmaceutical teams affecting diagnostic partnerships and early drug-Dx collaboration for effective biomarker strategy? • Are there ways in which each team throughout the industry can work more effectively together?Read more
day: Day One
11.20 | 8.20 Purpose Driven Approach to Biomarker Strategy & Planning: Hint… It Begins Early & Evolves with the Program 9:20 am
day: Day One